B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies

B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies

Background: Patients with primary antibody deficiencies are at risk in the current COVID-19 pandemic due to their impaired response to infection and vaccination. Specifically, patients with common variable immunodeficiency (CVID) generated poor spike-specific antibody and T cell responses after immu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Federica Pulvirenti, Ane Fernandez Salinas, Cinzia Milito, Sara Terreri, Eva Piano Mortari, Concetta Quintarelli, Stefano Di Cecca, Gianluca Lagnese, Alessandra Punziano, Marika Guercio, Livia Bonanni, Stefania Auria, Francesca Villani, Christian Albano, Franco Locatelli, Giuseppe Spadaro, Rita Carsetti, Isabella Quinti
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
common variable immunodeficiencies
SARS-CoV-2
COVID-1
BNT162b2
vaccine
third dose
Biology (General)
QH301-705.5
Acceso en línea:https://doaj.org/article/822e5cbd55774323bc3b29c8133a67df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/822e5cbd55774323bc3b29c8133a67df

Ejemplares similares